← Back
$DNTH All transactions

Dianthus Therapeutics, Inc. /DE/

▼ SELL 10b5-1 Plan

$ Value

$700K

Shares

20,000

Price

$35

Filed

Sep 11

Insider

Name

Savitz Ryan

Title

CFO & CBO

CIK

0001992324

Roles

Officer

Transaction Details

Transaction Date

2025-09-09

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2025. | The shares of common stock underlying this stock option award vested as to 25% of the shares on June 2, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Filing Info

Accession No.

0000950170-25-114293

Form Type

4

Issuer CIK

0001690585

Savitz Ryan's History

Date Ticker Type Value
2026-04-09 DNTH M $147K
2026-04-09 DNTH $739K
2026-04-09 DNTH M $0
2026-03-31 DNTH M $628K
2026-03-31 DNTH M $715K
2026-03-31 DNTH $109K
2026-03-31 DNTH $1.7M
2026-03-31 DNTH $119K
2026-03-31 DNTH $65K
2026-03-31 DNTH $196K

Other Insiders at DNTH (90d)

Insider Bought Sold Last
CARR EDWARD
CHIEF ACCOUNTING OFFICER
$3.6M 2026-03-12
Garcia Marino
CEO AND PRESIDENT
$10.0M 2026-03-12
Soteropoulos Paula $2.2M 2026-03-31
Veness Adam M
SVP, General Counsel and Sec.
2026-02-03
Randhawa Simrat
EVP, Head of R&D
$2.8M 2026-03-12
Savitz Ryan
EVP, CFO & CBO
$10.2M 2026-04-09